Eczema flare predictor device tested in new study

NCT ID NCT07645820

Recruiting now Knowledge-focused Sponsor: Castle Biosciences Incorporated Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a handheld device called Nevisense Go to see if it can predict eczema (atopic dermatitis) flares before they become visible or cause symptoms. About 450 people aged 12 to 89 with a history of eczema flares will use the device at home for 90 days. The goal is to develop an algorithm that can estimate the likelihood of a flare based on skin barrier measurements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Locations

Harrison Institute for Clinical Research
RECRUITING

Missouri City, Texas, 77459, United States
Las Vegas Dermatology
RECRUITING

Las Vegas, Nevada, 89144, United States
StracSkin, PLLC
RECRUITING

Portsmouth, New Hampshire, 03801, United States
U.S. Dermatology Partners
RECRUITING

Phoenix, Arizona, 85006, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.